·
1 Min Read

AMA statement on federal grant terminations for mental health, SUD care

The AMA is deeply concerned about the termination of federal grant funding for programs that support substance use disorder and mental health care.

Press Releases

Opioid and pain treatment CME

Address opioid and pain treatment with evidence-based training from Providers Clinical Support System-Medications for Opioid Use Disorders (PCSS-MOUD).

Supportive group holding hands
·
5 Min Read

Time for decisive action on substance-use disorder treatment

Progress is being made to prevent overdose deaths, but about 75,000 lives are still lost annually. The AMA outlines aggressive steps to save more lives.

Behavioral Health
Two colleagues in conversation
UPDATED
·
2 Min Read

Physicians’ progress toward ending the nation’s drug overdose epidemic

Learn more about physicians’ actions toward ending the nation’s overdose epidemic and improving care for patients with pain and substance use disorders (SUD). Download PDF of the Substance Use and Treatment Report.

Behavioral Health
·
3 Min Read

AMA 2025 report on substance use and treatment

New report shows drop in overdose deaths and calls on policymakers to remove obstacles to evidence-based care. 

Press Releases

Membership Moves Medicine™

  • Free access to JAMA Network™ and CME
  • Save hundreds on insurance
  • Fight for physicians and patient rights
UPDATED
·
9 Min Read

AMA Advocacy issue briefs

Download PDFs of issue briefs that summarize key health policy issues by providing concise and digestible content for both relevant stakeholders and those who may know little about the topic.

Federal Advocacy
Naloxone spray
·
5 Min Read

Naloxone can sustain our progress in fighting overdose deaths

Fatal drug overdoses fell 25% last year, sparking hope. Here are five practical steps we should take next to save lives.

series
Leadership
Leadership Viewpoints
Patient reads a prescription
·
3 Min Read

New FDA opioid labeling keep focus on individualized care

Agency action updates medication risk information and supports prescribing decisions tailored to individual patient needs. 

Behavioral Health
·
1 Min Read

On opioid labeling, FDA emphasizes patient-physician relationship

The AMA commends the FDA for new label requirements for opioids that emphasizes shared decision-making between the patient and physician.

Press Releases
AMA Update for May 21, 2025: Cancer in people under 50, overdose deaths down, syphilis testing during pregnancy plus measles news
·
11 Min Read

Cancer in people under 50, overdose deaths down, syphilis testing during pregnancy plus measles news

The AMA Update covers a range of health care topics affecting the lives of physicians and patients. Learn more about cancer in people under 50, syphilis and more.

series
Chronic Diseases
AMA Update